1 / 10

National injecting conference

National injecting conference. Annette Dale-Perera Director of Quality . Context: expansion in drug treatment. Rapid expansion in structured drug treatment Improvements in access: reduced waiting times, more offenders Rapid increase in drug treatment workforce

sani
Download Presentation

National injecting conference

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. National injecting conference Annette Dale-Perera Director of Quality

  2. Context: expansion in drug treatment • Rapid expansion in structured drug treatment • Improvements in access: reduced waiting times, more offenders • Rapid increase in drug treatment workforce • New NTA push on “Treatment Effectiveness” with service users fully involved in care

  3. Most injectors in contact with drug treatment ? • Structured drug treatment: approx 160,000 people in 04/05 – 56% injectors – 90,000 • Needle exchange services: 105,000 people (overlap unknown) • Estimates of injectors in England: 150-210,000 people • New populations being drawn in via DIP & prison work • DIP 3000 assessed per month, most not had treatment, 35% injected in last month – high reported levels of sharing • About 15,000 04/05 in treatment referred from CJ • Prison work especially CARATS

  4. Harm • Increasing infections (Nicolas Beeching) • New, worrying patterns of drug taking: Nexus of Risk re crack use in the context of injecting (Tim Rhodes) • Increasing BBV (Viv Hope) • Hep B 1: 5 • Hep C 2: 5 some areas higher - many unaware • HIV increasing • More drug users with serious long term health problems • But some good news …….Overdose Deaths are falling

  5. What are we trying to achieve ? Harm reduction as core activity in all drug treatment • Injecting is high risk behaviour • Interventions to reduce risk and improve health ie change behaviour • Harm reduction interventions to help injectors reduce harm: • Raise awareness amongst drug injectors • Safer injecting techniques to stop spread of Blood borne Virus’s, infection, etc • Injecting equipment dispersal and return • Overdose prevention inc alcohol treatment, naloxone, first aid etc • Reduce initiation into injecting • Opiate substitution treatment: at the right dose • Reduce and ideally stop injecting • Continuity of drug treatment • Reduce risks to others from injecting eg disposal

  6. So why have we got an increase in injecting related harm ? • Continued focus in national guidance on harm reduction, Models of Care 2002, reducing drug related deaths 2004 • 30% staff new: need better competence to work with injectors ? • Some work not monitored as structured treatment and HR not stressed enough in structured treatment • NX not proactive enough eg 80% pharmacy based • Drug trends and trends in BBV ?

  7. National needle exchange audit 04/05 Abdulrahim &Hunt Key finding is VARIATION in range and type of NX On the surface every DAT in country has some but • 10% rely on pharmacy based exchange only • 40%-60% have no on-site testing for BBV Specialist NX initial assessment • 15% did not cover risks sharing injecting equipment • 25% did not cover OD risk • Under 65% covered injecting hygiene, vein care • Only 35% provided dressings/care for minor infections

  8. Improvement required incommissioning & provision • More testing and awareness of BBV status • Better health care: Hep B vacs, check injection sites, abscesses • More proactive NX and open access: pharmacy alone is not enough • MORE COMPETENT STAFF: more training • More work with injecting in structured drug treatment • Getting the dose right in prescribing • Greater users involvement in design and delivery of services

  9. NTA/HealthCare CommissionImprovement Review National improvement review and inspection of Harm reduction services 06/07 • National criteria (standards) and programme developed 05/6 • Every area screened against criteria and data: summer 06 • Every area receive a report Dec 2006 • 10% “inspected” (inc peer review) By March 2007 • Each area with an action plan to improve harm reduction • Good practice “benchmarked” and identified • Action to improve commissioning, monitoring and provision

  10. Conclusions • Local drug treatment systems need to provide better services to help injectors reduce harm • We are already in contact with the majority: we need to question whether we doing enough to reduce harm THANK YOU Conference organisers and attendees Events like this will help

More Related